Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI)replacement - Pfizer Inc

6th May 2014 16:16

RNS Number : 3878G
Morgan Stanley Capital Services LLC
06 May 2014
 



AMENDMENT  

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

01 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 286,156

 31.5600 USD

 30.9500 USD

 COMMON STOCK

 SALES

 307,578

 31.5700 USD

 30.9600 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 5,900

 31.0327 USD

 COMMON STOCK

 CFD

 LONG

 3

 31.0600 USD

 COMMON STOCK

 CFD

 LONG

 9,912

 31.0679 USD

 COMMON STOCK

 CFD

 LONG

 901

 31.0680 USD

 COMMON STOCK

 CFD

 LONG

 200

 31.0750 USD

 COMMON STOCK

 CFD

 LONG

 1,900

 31.0942 USD

 COMMON STOCK

 CFD

 LONG

 60,400

 31.1018 USD

 COMMON STOCK

 CFD

 LONG

 39,600

 31.1018 USD

 COMMON STOCK

 CFD

 LONG

 5,400

 31.1074 USD

 COMMON STOCK

 CFD

 LONG

 7,042

 31.1164 USD

 COMMON STOCK

 CFD

 LONG

 52,600

 31.1221 USD

 COMMON STOCK

 CFD

 LONG

 1,800

 31.1308 USD

 COMMON STOCK

 CFD

 LONG

 11,400

 31.1308 USD

 COMMON STOCK

 CFD

 LONG

 94,400

 31.1416 USD

 COMMON STOCK

 CFD

 LONG

 8,100

 31.1912 USD

 COMMON STOCK

 CFD

 LONG

 1,100

 31.2800 USD

 COMMON STOCK

 CFD

 LONG

 5,700

 31.4020 USD

 COMMON STOCK

 CFD

 SHORT

 2,100

 31.0392 USD

 COMMON STOCK

 CFD

 SHORT

 8,178

 31.0586 USD

 COMMON STOCK

 CFD

 SHORT

 2,100

 31.0800 USD

 COMMON STOCK

 CFD

 SHORT

 16,700

 31.0815 USD

 COMMON STOCK

 CFD

 SHORT

 11,755

 31.0962 USD

 COMMON STOCK

 CFD

 SHORT

 108,800

 31.1123 USD

 COMMON STOCK

 CFD

 SHORT

 5,754

 31.1143 USD

 COMMON STOCK

 CFD

 SHORT

 92,945

 31.1170 USD

 COMMON STOCK

 CFD

 SHORT

 400

 31.1275 USD

 COMMON STOCK

 CFD

 SHORT

 303

 31.1349 USD

 COMMON STOCK

 CFD

 SHORT

 2,021

 31.1349 USD

 COMMON STOCK

 CFD

 SHORT

 3,367

 31.1366 USD

 COMMON STOCK

 CFD

 SHORT

 306

 31.1366 USD

 COMMON STOCK

 CFD

 SHORT

 2

 31.1600 USD

 COMMON STOCK

 CFD

 SHORT

 13

 31.1600 USD

 COMMON STOCK

 CFD

 SHORT

 846

 31.1698 USD

 COMMON STOCK

 CFD

 SHORT

 23

 31.1698 USD

 COMMON STOCK

 CFD

 SHORT

 9,695

 31.1786 USD

 COMMON STOCK

 CFD

 SHORT

 344

 31.1951 USD

 COMMON STOCK

 CFD

 SHORT

 720

 31.1989 USD

 COMMON STOCK

 CFD

 SHORT

 1,055

 31.2000 USD

 COMMON STOCK

 CFD

 SHORT

 1,690

 31.2012 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

06 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEREASSKEFSLEFF

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,723.36
Change43.07